← Eichor
Study identifier: NCT06787274 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Research on Equity in Abortion Care by TeleHealth

Condition: Abortion in First Trimester · Abortion Early · Abortion; Attempted  ·  Sponsor: University of California, San Francisco

PhaseN/A
Planned participants2000
Who can joinAll sexes, 14 Years to 64 Years
Healthy volunteersYes

About this study

This study will examine the ways in which telehealth for reproductive healthcare affects timing, costs, and follow-up care; whether telehealth reaches people in areas with greater health inequities; and the attributes of telehealth that patients want. Study surveys will be administered to interested, eligible participants: 2,000 patients seeking abortion care will complete the study, comprising of 2 groups: patients seeking medication abortion care either (1) in-person or (2) via telehealth. This project will address how telehealth services can be optimized for people of color, low-income people, and immigrants to increase digital inclusion and health equity.

This description comes directly from the study's public registry record.

Talk to the study team

Ushma Upadhyay, PhD, MPH  ·  415-353-4626  ·  ushma.upadhyay@ucsf.edu

Jennifer Ko, MLIS  ·  415-353-9113  ·  jennifer.ko@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Advancing New Standards in Reproductive Health (ANSIRH)Oakland, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06787274